NDC 10122-502-01
Revcovi 1.6 mg/mL
elapegademase-lvlr · INJECTION
Revcovi is an injectable medication given as an intramuscular injection used to treat adenosine deaminase (ADA) deficiency, a rare genetic disorder affecting the immune system. It works by replacing the missing or defective enzyme that the body cannot produce on its own.
Key Facts
- Brand Name
- Revcovi
- Generic Name
- elapegademase-lvlr
- NDC Code (Package)
10122-502-01- NDC Code (Product)
10122-502- Manufacturer
- Chiesi USA, Inc.
- Strength
- 1.6 mg/mL
- Dosage Form
- INJECTION
- Route
- INTRAMUSCULAR
- Marketing Status
- Application #
- BLA761092
- Marketing Start
- 10/05/2018
Recall History
No Recall HistoryView Full Drug Page
Revcovi — All PackagesNot medical advice. This information is for reference only. Always consult your doctor or pharmacist.